1975-2017, date created

Personal name, Coffey, Donald Straley

Donald S. Coffey, a professor of urology, oncology, pathology, and pharmacology and molecular sciences at the Johns Hopkins University School of Medicine, was born in Bristol, Tennessee. He received his bachelor’s degree from the East Tennessee State University in 1957. After working as a chemist for the North American Rayon Co. in Elizabethton, Tennessee during his last two years of college, Coffey took a job as an associate chemical engineer at the Westinghouse Electronic Corporation in Baltimore after graduation.
Coffey aspired to a career in cancer research. While his academic credits at the time were not sufficient for admission to graduate school, he was able to attend evening classes at Johns Hopkins' McCoy College. While there, he was hired to work nights at the Brady Urological Research Laboratory. Coffey became acting director of the lab for the year 1959-1960. With encouragement, Coffey applied for the graduate program in the Johns Hopkins University School of Medicine Department of Physiological Chemistry, where he earned his Ph.D. in 1964 and completed postdoctoral research.
Coffey became director of the Brady Laboratory for Reproductive Biology in 1969 and held the position until 1974, when it merged with the Brady Research Laboratory. He directed this lab for the next thirty years.
Coffey's career at Johns Hopkins was interdisciplinary. He was appointed assistant professor in the Department of Pharmacology and Experimental Therapeutics in 1966, then promoted to associate professor. He served as acting chairman of the department in 1973-1974. The Department of Oncology appointed Coffey an associate professor in 1973, and then professor in 1974. In 1975, he was named the Catherine Iola and J. Smith Michael Distinguished Professor of Urology. From 1987 to 1992, Coffey served as deputy director of the Johns Hopkins Oncology Center. In 1988, he was appointed professor in the Department of Pathology. After many years of service in several departments and capacities throughout Johns Hopkins, Coffey was appointed professor emeritus of urology, oncology, pathology, and pharmacology and experimental therapeutics in 2016.
His research focused on understanding nuclear structure and DNA organization in normal and cancerous cells, as well as how androgens affect prostate growth and the function of genes. He discovered a nuclear scaffolding system, dubbed the “nuclear matrix,” where DNA synthesis occurs. Coffey was also part of a team that used a testicular cancer model to show that cancer cells exposed to heat are more responsive to anticancer drugs and radiation therapy. In addition, he was responsible for providing the groundwork for identifying telomerase abnormalities in prostate cancer, which led to the first prostate cancer gene therapy trials. His lab at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center worked on a stem cell model to explain why benign prostatic hyperplasia never develops to form prostate adenocarcinomas. This discovery presented a new model for understanding prostate cancer.
Coffey also is credited with helping recruit and train many of the Johns Hopkins Kimmel Cancer Center’s prominent investigators. He served on many School of Medicine committees and boards, including the President’s Committee on Governance; the Medical School Council; the Advisory Board; the Committee on Educational Policy and Curriculum; the Professional Promotions Committee; the Medical Scientist Training Program; and the Committee on Cultural and Social Affairs. He published more than 290 research papers and served on the editorial board of twelve scientific journals including The Journal of Urology, Pharmacology and Therapeutics, Investigative Urology, Urologic Oncology, Urology, and the World Journal of Urology.
For nineteen years, Coffey was a member of the National Prostatic Cancer Program of the National Cancer Institute and served as national chairperson from 1984 to 1988. He was president of the American Association of Cancer Research, and served six years on the National Cancer Advisory Board. His many awards include both the Fuller Award and the Lifetime Achievement Award from the American Urological Association, the Society of International Urology-Yamanouchi Research Award, a 2001 American Cancer Society Distinguished Service Award, and two Merit Awards from the National Institutes of Health. In 2015, he received the American Association for Cancer Research’s Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research.

Johns Hopkins Hospital, 1959-2017

Johns Hopkins University School of Medicine, 1960-2017

Deputy Director, The Johns Hopkins Oncology Center, 1987-1992

Principal Professional Staff, The Johns Hopkins Applied Physics Laboratory, 1992-

The Catherine Iola and J. Smith Michael Distinguished Professor of Urology, 1988

2018-087

2006-130

2006-114

2001-079